Last Updated: June 22, 2026

PILOCARPINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pilocarpine patents expire, and when can generic versions of Pilocarpine launch?

Pilocarpine is a drug marketed by Amneal, Fdc Ltd, Rising, Somerset Theraps Llc, Aurobindo Pharma Usa, Impax Labs, Innogenix, Lannett Co Inc, and Padagis Us. and is included in ten NDAs.

The generic ingredient in PILOCARPINE is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pilocarpine

A generic version of PILOCARPINE was approved as pilocarpine hydrochloride by INNOGENIX on December 22nd, 2004.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for PILOCARPINE?
  • What are the global sales for PILOCARPINE?
  • What is Average Wholesale Price for PILOCARPINE?
Summary for PILOCARPINE
US Patents:0
Applicants:9
NDAs:10
Drug Prices: Drug price information for PILOCARPINE
DailyMed Link:PILOCARPINE at DailyMed
Recent Clinical Trials for PILOCARPINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Southern College of OptometryPHASE4
Mansoura UniversityNA
Novus Vision LLCEARLY_PHASE1

See all PILOCARPINE clinical trials

Medical Subject Heading (MeSH) Categories for PILOCARPINE

US Patents and Regulatory Information for PILOCARPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride SOLUTION/DROPS;OPHTHALMIC 214193-001 Sep 21, 2020 AT RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Innogenix PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride TABLET;ORAL 076963-001 Dec 22, 2004 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fdc Ltd PILOCARPINE HYDROCHLORIDE pilocarpine hydrochloride SOLUTION/DROPS;OPHTHALMIC 217052-003 Oct 2, 2025 AT RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.